-
FDA grants EUA for Merck-Ridgeback’s oral Covid-19 antiviral molnupiravir
Pharmaceutical-Technology
December 27, 2021
The authorisation is based on positive results from the Phase III MOVe-OUT trial of molnupiravir in adult Covid-19 patients.
-
FDA grants fast track designation to Eisai-Biogen’s Alzheimer’s therapy
Pharmaceutical-Technology
December 27, 2021
The US Food and Drug Administration (FDA) has granted Fast Track designation to Eisai and Biogen’s experimental drug, lecanemab, to treat early Alzheimer’s disease (AD).
-
FDA grants EUA for Pfizer’s Covid-19 oral antiviral Paxlovid
Pharmaceutical-Technology
December 24, 2021
The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for Pfizer’s oral antiviral Paxlovid to treat mild-to-moderate Covid-19 in adults and paediatric individuals aged 12 years and above.
-
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
prnewswire
December 23, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease...
-
FDA Authorizes First Oral Antiviral for Treatment of COVID-19
WorldPharmaNews
December 23, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease...
-
First drug for acute graft-versus-host disease prevention approved by FDA
EuropeanPharmaceuticalReview
December 23, 2021
BMS’s Orencia (abatacept) has been approved by the US FDA for prophylaxis of acute graft-versus-host disease (aGvHD) in patients aged two years plus.
-
FDA Gives OK to Merck's Antiviral At-Home COVID Pill
drugs
December 23, 2021
Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19.
-
FDA Gives OK to Merck Antiviral At-Home COVID-19 Pill
drugs
December 23, 2021
Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19.
-
FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations
FDA
December 22, 2021
FDA has approved Xarelto (rivaroxaban) as tablets and an oral suspension to treat venous thromboembolism (VTE), or blood clots that form in the veins, and reduce the risk of VTE recurring in pediatric patients...
-
FDA Approves Pfizer Pill as First At-Home COVID-19 Treatment
drugs
December 22, 2021
The U.S. Food and Drug Administration on Wednesday approved the emergency use of the new Pfizer antiviral pill Paxlovid in people who are at high risk for severe COVID-19.